While this week’s news of one major vaccine candidate for COVID-19 having reached the Phase III trials stage with a goal of 30,000 volunteer patients is encouraging in many respects, […]
Tomorrow’s clinical trials workforce will face demands and expectations almost unimaginable today. To thrive, the workforce is going to need a new level of training, greater diversity, and richer understanding […]
“Long-standing systemic health and social inequities have put some members of racial and ethnic minority groups at increased risk of getting COVID-19 or experiencing severe illness, regardless of age,” the […]
Average total time to conduct clinical studies and then complete the approval phase increased by 4.8 months from 2008–13 to 2014–18, according to a new report by the Tufts Center […]
While anecdotal evidence and data from the U.S. Food and Drug Administration (FDA) suggest progress has been incremental at best, former clinical research associate (CRA) Sharon Duffy remains “optimistic” that […]